Cardiol Therapeutics (CRDL) Debt to Equity: 2021
Historic Debt to Equity for Cardiol Therapeutics (CRDL) over the last 1 years, with Dec 2021 value amounting to $0.09.
- Cardiol Therapeutics' Debt to Equity was N/A to $0.01 in Q3 2022 from the same period last year, while for Dec 2021 it was $0.09, marking a year-over-year change of. This contributed to the annual value of $0.09 for FY2021, which is N/A change from last year.
- According to the latest figures from FY2021, Cardiol Therapeutics' Debt to Equity is $0.09.
- In the past 5 years, Cardiol Therapeutics' Debt to Equity ranged from a high of $0.09 in FY2021 and a low of $0.09 during FY2021.
- Moreover, its 1-year median value for Debt to Equity was $0.09 (2021), whereas its average is $0.09.